ACOG Practice Bulletin No. 108: Polycystic ovary syndrome.
Polycystic ovary syndrome (PCOS) is a disorder characterized by hyperandrogenism, ovulatory dysfunction, and polycystic ovaries. Its etiology remains unknown, and treatment is largely symptom based and empirical. PCOS has the potential to cause substantial metabolic sequelae, including an increased risk of diabetes and cardiovascular disease, and these factors should be considered when determining long-term treatment. The purpose of this document is to examine the best available evidence for the diagnosis and clinical management of PCOS.
D003277:Contraceptives, Oral, Combined / Q000627:therapeutic use*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D005260:Female; D006628:Hirsutism / Q000150:complications / Q000188:drug therapy; D006801:Humans; D017588:Hyperandrogenism / Q000150:complications / Q000175:diagnosis; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D011085:Polycystic Ovary Syndrome / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy*
D003277:Contraceptives, Oral, Combined; D007004:Hypoglycemic Agents